MK0686 in Postsurgery Dental Pain (0686-002)

• Status: Completed
• Trial end date: 2004-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed

• Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

• Patient has history of heart disease, asthma, pulmonary disease

• Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery